Deals this week: Bayer AG, Plasticell, Sarepta Therapeutics
Bayer AG and Evotec AG have entered a multi-target research partnership agreement to develop novel treatments for chronic kidney disease in diabetic patients.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Chronic Kidney Disease | Diabetes | Endocrinology | Partnerships | Pharmaceuticals | Urology & Nephrology